RACHEL L MITCHELL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SHELBYVILLE, TN NPI 1992091995
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TN NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$7,408.81
- Category: General Payments
- Program years: PY2018–2024
- Record count: 316
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $648.41 across 25 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $648.41 | 25 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $125.89 | 5 |
| GENZYME CORPORATION | $82.00 | 2 |
| Daiichi Sankyo Inc. | $81.21 | 3 |
| PFIZER INC. | $44.86 | 2 |
| Verity Pharmaceuticals Inc. | $42.38 | 2 |
| E.R. Squibb & Sons, L.L.C. | $41.52 | 2 |
| Merck Sharp & Dohme Corporation | $33.10 | 1 |
| Ipsen Biopharmaceuticals, Inc | $31.79 | 1 |
| Acerta Pharma LLC | $31.07 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.17 | 1 |
| Deciphera Pharmaceuticals Inc. | $26.90 | 1 |
| Astellas Pharma US Inc | $22.62 | 1 |
| SERVIER PHARMACEUTICALS LLC | $21.12 | 1 |
| ADC Therapeutics America, Inc. | $19.75 | 1 |
| Celgene Corporation | $17.03 | 1 |
By program year
Records — PY2024 (25)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.